Pharmacoeconomic analysis of type 2 diabetes mellitus by vildagliptin medication in Kazakhstan

Abstract

This study is aimed to determine cost-effectiveness of vildagliptin in comparison with sitagliptin for the treatment of patients with type 2 diabetes mellitus (T2DM) from the perspective of Ministry of Health of the Republic of Kazakhstan.